Focused Ultrasound Foundation interview with Roel Deckers about breast cancer study
On October 8, Royal Philips Electronics announced that its investigational MR-guided focused ultrasound system had treated the first breast cancer patient in a pilot clinical trial at the University Medical Center Utrecht (UMC) in the Netherlands. The company described the design of the new device as \"optimized for the anatomy of the female breast.\" The study is expected to treat nine more patients with localized breast tumors in coming months. Treatments are not intended to destroy tumors. Instead, they are assessing the image quality, safety and precision of the Philips system. Patients are receiving single or multiple noninvasive focused ultrasound sonications and subsequently undergo a conventional surgical procedure for tumor removal.From:FUSFoundationViews:3 0ratingsTime:02:18More inScience Technology<\/p>\n
Follow this link: Focused Ultrasound Foundation interview with Roel Deckers about breast cancer study On October 8, Royal Philips Electronics announced that its investigational MR-guided focused ultrasound system had treated the first breast cancer patient in a pilot clinical trial at the University Medical Center Utrecht (UMC) in the Netherlands. The company described the design of the new device as \"optimized for the anatomy of the female breast.\" The study is expected to treat nine more patients with localized breast tumors in coming months Continue reading
\nFocused Ultrasound Foundation interview with Roel Deckers about breast cancer study - Video<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"